ELVN - Enliven Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$69.50
DETAILS
HIGH:
$80.00
LOW:
$59.00
MEDIAN:
$69.50
CONSENSUS:
$69.50
UPSIDE:
67.31%
Metrics Summary
Market Cap:
2.53B
Volume:
632,207
Avg Volume:
1,097,869
52 Week Range:
14.785-48.53
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.45
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
62
IPO Date:
2020-03-12